5-hydroxymethylomeprazole has been researched along with 5-hydroxylansoprazole in 1 studies
| Studies (5-hydroxymethylomeprazole) | Trials (5-hydroxymethylomeprazole) | Recent Studies (post-2010) (5-hydroxymethylomeprazole) | Studies (5-hydroxylansoprazole) | Trials (5-hydroxylansoprazole) | Recent Studies (post-2010) (5-hydroxylansoprazole) |
|---|---|---|---|---|---|
| 54 | 17 | 15 | 9 | 2 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babaoglu, MO; Balamtekin, N; Baysoy, G; Bozkurt, A; Demir, H; Gumus, E; Karaca, O; Uslu, N; Yasar, U; Yuce, A | 1 |
1 other study(ies) available for 5-hydroxymethylomeprazole and 5-hydroxylansoprazole
| Article | Year |
|---|---|
Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Aryl Hydrocarbon Hydroxylases; Biotransformation; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Female; Gene Frequency; Genetic Association Studies; Hospitals, Pediatric; Humans; Lansoprazole; Male; Omeprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Turkey | 2012 |